These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 3624507)

  • 41. Propranolol, depression, and nortriptyline interaction.
    Neppe VM
    Am J Psychiatry; 1984 Aug; 141(8):1009-10. PubMed ID: 6465354
    [No Abstract]   [Full Text] [Related]  

  • 42. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Ruhe HG; Horikx A; van Avendonk MJP; Groeneweg BF; Woutersen-Koch H;
    Lancet Psychiatry; 2019 Jul; 6(7):561-562. PubMed ID: 31230677
    [No Abstract]   [Full Text] [Related]  

  • 43. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Kronenberg G; Desai D; Anghelescu I
    Lancet Psychiatry; 2019 Jul; 6(7):560. PubMed ID: 31230675
    [No Abstract]   [Full Text] [Related]  

  • 44. Tapering of SSRI treatment to mitigate withdrawal symptoms.
    Selvaraj S; Jauhar S; Baldwin DS; Cowen PJ; Goodwin G; Hayes JF; Nutt DJ; Veronese M; Young AH
    Lancet Psychiatry; 2019 Jul; 6(7):560-561. PubMed ID: 31230676
    [No Abstract]   [Full Text] [Related]  

  • 45. Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply.
    Horowitz MA; Taylor D
    Lancet Psychiatry; 2019 Jul; 6(7):562-563. PubMed ID: 31230678
    [No Abstract]   [Full Text] [Related]  

  • 46. Antidepressant discontinuation syndromes.
    Haddad PM
    Drug Saf; 2001; 24(3):183-97. PubMed ID: 11347722
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychosis after discontinuation of nortriptyline.
    Patterson JF
    J Clin Psychopharmacol; 1984 Apr; 4(2):117-8. PubMed ID: 6707238
    [No Abstract]   [Full Text] [Related]  

  • 48. A retrospective study of serum levels and electrocardiographic effects of nortriptyline in children and adolescents.
    Wilens TE; Biederman J; Spencer T; Geist DE
    J Am Acad Child Adolesc Psychiatry; 1993 Mar; 32(2):270-7. PubMed ID: 8444754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Child and adolescent nortriptyline single dose kinetics predict steady state plasma levels and suggested dose: preliminary data.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Price DT; Yates E
    J Clin Psychopharmacol; 1985 Jun; 5(3):154-8. PubMed ID: 3998205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Withdrawal symptoms in critically ill children after long-term administration of sedatives and/or analgesics: a first evaluation.
    Ista E; van Dijk M; Gamel C; Tibboel D; de Hoog M
    Crit Care Med; 2008 Aug; 36(8):2427-32. PubMed ID: 18596622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term amitriptyline in chronic depression.
    Giller E; Bialos D; Harkness L; Jatlow P; Waldo M
    Hillside J Clin Psychiatry; 1985; 7(1):16-33. PubMed ID: 3894196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective study of scheduled withdrawal from nortriptyline in children and adolescents.
    Geller B; Cooper TB; Carr LG; Warham JE; Rodriguez A
    J Clin Psychopharmacol; 1987 Aug; 7(4):252-4. PubMed ID: 3624507
    [TBL] [Abstract][Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.